Unstable angina / non ST elevation myocardial infarction prehospital care before onset
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina / non ST elevation myocardial infarction prehospital care before onset On the Web |
FDA on Unstable angina / non ST elevation myocardial infarction prehospital care before onset |
CDC onUnstable angina / non ST elevation myocardial infarction prehospital care before onset |
Unstable angina / non ST elevation myocardial infarction prehospital care before onset in the news |
Blogs on Unstable angina / non ST elevation myocardial infarction prehospital care before onset |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
Overview
- Major risk factors for development of coronary heart disease have been established from several long term epidemiological studies[1] [2].
- Various clinical trials have demonstrated that development of coronary diseases can be prevented or the risk of experiencing UA/NSTEMI in patients who have coronary heart disease can be lowered by modifying these risk factors[3][4][5].
- The risk factors include:
- Smoking
- Overweight or obese
- Abnormal lipid profile
- Diabetes Mellitus
- Elevated blood pressure
- Physical inactivity
- Advanced age
- 10 year risk of developing coronary heart disease can be assessed using calculator based on Framingham Heart Study[6] here.
References
- ↑ "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report". Circulation. 106 (25): 3143–421. 2002. PMID 12485966. Retrieved 2011-04-11. Unknown parameter
|month=
ignored (help) - ↑ Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, Wolf PA, Levy D (2006). "Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age". Circulation. 113 (6): 791–8. doi:10.1161/CIRCULATIONAHA.105.548206. PMID 16461820. Retrieved 2011-04-11. Unknown parameter
|month=
ignored (help) - ↑ Ross SD, Allen IE, Connelly JE, Korenblat BM, Smith ME, Bishop D, Luo D (1999). "Clinical outcomes in statin treatment trials: a meta-analysis". Archives of Internal Medicine. 159 (15): 1793–802. PMID 10448784. Retrieved 2011-04-12.
- ↑ Wilson K, Gibson N, Willan A, Cook D (2000). "Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies". Archives of Internal Medicine. 160 (7): 939–44. PMID 10761958. Retrieved 2011-04-12. Unknown parameter
|month=
ignored (help) - ↑ Smith SC, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K, Fuster V, Gotto A, Grundy SM, Miller NH, Jacobs A, Jones D, Krauss RM, Mosca L, Ockene I, Pasternak RC, Pearson T, Pfeffer MA, Starke RD, Taubert KA (2001). "AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology". Circulation. 104 (13): 1577–9. PMID 11571256. Retrieved 2011-04-12. Unknown parameter
|month=
ignored (help) - ↑ "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)". JAMA : the Journal of the American Medical Association. 285 (19): 2486–97. 2001. PMID 11368702. Retrieved 2011-04-12. Unknown parameter
|month=
ignored (help)